Free option on their own operations: management describes a real capability it already owns that could serve a second, m
The model's full reasoning — Q3 2018 call → NOWe need answer YES or NO based on transcript. Need identify if management describes existing capability used for second larger purpose and already converting with little revenue. Let's parse transcript. Company Surmodics. They have medical device coatings, IVD, etc. They developed SurVeil drug-coated balloon, partnered with Abbott for commercialization. They supply SurVeil to Abbott, collaborate. Revenue from Abbott $1.7M in quarter, license fee. Is that existing capability? SurVeil built on next generation technology including proprietary drug-excipient formulation and manufacturing process. They already had this technology. Abbott deal gives worldwide commercialization rights. This is second use? Actually SurVeil is their product, they developed it. Abbott will commercialize. Is that "something company already owns and operates for existing business has turned out useful for second, much larger purpose"? Hmm. Another possibility: Their coating technology and design capabilities used for whole product solutions. They have hydrophilic coatings used in medical devices. They developed catheters (Telemark, .014, .018) using their coating and shaft technology. They are seeking partners. But that's new products, not second use of existing capability? They already have coating technology and manufacturing. They are using it to make own devices. That is a second use of their coating technology? They historically sold coatings to other device makers. Now they use their own coating technology to make whole products (catheters, balloons). That is a second use: from supplying coatings to making devices. Is it bigger? They say "on track to become leading medical device innovator", goals double-digit growth, EBITDA margins. They have regulatory clearances, clinical evaluations, interested parties. Revenue from product sales increased 49% due to balloon catheter unit volume. But is that second use already converting? They have product sales, but not necessarily from new whole products? They mention product sales increased due to balloon catheter unit volume as result of recent customer product launches and increased reagent sales. Wait "recent customer product launches" might be coatings on customers' products, not own devices. They have own .014, .018 balloons, Telemark microcatheter.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| SANG | Sangoma Technologies Corporation | Q2 2024 | 2024-02-08 | D |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| GGR | Gogoro Inc. | Q1 2023 | 2023-05-11 | D |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| PRPO | Precipio, Inc. | Q3 2018 | 2018-11-19 | D |
HCKT · Q1 2024 → YESThe question is about whether management describes something the company already owns and operates that has turned out useful for a second, much larger purpose, and they've begun turning that into rea...
HUYA · Q4 2023 → YESThe question is whether management describes something the company already owns and operates that has turned out useful for a second, much larger purpose, and they've begun turning that into real busi...
SANG · Q2 2024 → YESThe question is about whether management describes something the company already owns and operates that has turned out useful for a second, much larger purpose, and they've begun turning that into rea...